Abstract
Background: Results of surgical treatment in Indian patients of Ewing’s sarcoma managed with multimodality treatment with chemotherapy and/or radiotherapy are insufficient. We report a retrospective evaluation of a series of cases of Ewing’s sarcoma managed with chemotherapy, surgery with or without radiotherapy.
Materials and Methods: 54 patients of biopsy-proven Ewing’s sarcoma of the bone, except craniofacial and vertebral bones were included. The patients having recurrence or having previous treatment were excluded from the study. Local and systemic extent of the sarcoma was defined, staged, and patients were subjected to the chemotherapy, surgery, and in some cases radiotherapy. Patients were evaluated for results of surgery with respect to complications, recurrence, and metastases at 3, 6, 9, 12, 18 and 24 months of follow-up
Results: Average age of patients was 15.6 years (range 7–26 years); average delay in treatment was 4.1 months (1–7 months); follow-up ranged from 2 to 5 years (median 3.1 years); 14 patients (25.9%) had pulmonary metastases at their initial presentation. Twenty-one patients (38.9%) underwent resection and intercalary reconstruction with bone grafting, fixed with locking plates. Allograft was also used in 11 of these. Sixteen patients underwent resection and reconstruction with endoprosthesis, while seven patients (13.0%) underwent resection and arthrodesis. An above-knee amputation was required in 7.4% (four patients). Mesh was used for containing the graft longitudinally in five patients (femoral and tibial intercalary reconstructions) and for soft tissue attachment in two patients (hip and shoulder endoprostheses). Two patients had deep wound infection. One patient presented 1 year later with implant failure. The disease-free survival at 2 years from the time of diagnosis was 57.5% (23 out of 40) for patients without preoperative metastases and 42.9% (6 out of 14) for those with preoperative metastases. Overall, the disease-free survival at 2 years was 53.7% (29 out of 54 patients). Overall survival rate at 2 years was 61.1% (33 out of 54 patients).
Conclusion: Results of surgical treatment in this study are comparable with the current literature in spite of involvement of long bony segment and large soft tissue component. Intramedullary fibular autograft with morcellized cancellous autograft and allograft contained longitudinally in a mesh appears to be a good alternative with such large bone tumors.
Similar content being viewed by others
References
Pramanik R, Parai CC, Ghosh A. Pattern of solid malignant tumours in children-a ten-year study. J Indian Med Assoc 1997;95:107–8.
Yeole BB, Jussawalla DJ. Descriptive epidemiology of bone cancer in greater Bombay. Indian J Cancer 1998;35:101–6.
Rao VS, Pai MR, Rao RC, Adhikary MM. Incidence of primary bone tumours and tumour like lesions in and around Dakshina Kannada district ofKarnataka. J Indian Med Assoc 1996;94:103–4.
Bacci G, Toni A, Avella M, Manfrini M, Sudanese A, Ciaroni D, et al. Long-term results in 144 localized Ewing’s sarcoma patients treated with combined therapy. Cancer 1989;63:1477–86.
Aparicio J, Munárriz B, Pastor M, Vera FJ, Castel V, Aparisi F, et al. Long-term follow-up and prognostic factors in Ewing’s sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology 1998;55:20–6.
Iyer RS, Rao SR, Gurjal A, Nair CN, Pai SK, Kurkure PA, et al. Ewing’s sarcoma. J Surg Oncol 1993;52:188–92.
Sluga M, Windhager R, Lang S, Heinzl H, Krepier P, Mittermayer F, et al. A long-term review of the treatment of patients with Ewing’s sarcoma in one institution. Eur J Surg Oncol 2001;27:569–73.
Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, et al. Fryer Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694–701.
Sailer SL, Harmon DC, Mankin HJ, Truman JT, Suit HD. Ewing’s sarcoma: surgical resection as a prognostic factor. Int J Radiat Oncol Biol Phys 1988;15:43–52.
Wilkins RM, Pritchard DJ, Burgert EO Jr, Unni KK. Ewing’s sarcoma of bone. Experience with 140 patients. Cancer 1986;58:2551–5.
Clohisy DR, Mankin HJ. Osteoarticular allografts for reconstruction after resection of a musculoskeletal tumor in the proximal end of the tibia. J Bone Joint Surg Am 1994;76:549–54.
Gitelis S, Piasecki P. Allograft prosthetic composite arthroplasty for osteosarcoma and other aggressive bone tumors. Clin Orthop Relat Res 1991;270:197–201.
Mankin HJ, Doppelt SH, Sullivan TR, Tomford WW. Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone. Cancer 1982;50:613–30.
Mankin HJ, Gebhardt MC, Jennings LC, Springfield DS, Tomford WW. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res 1996;324:86–97.
Mnaymneh W, Malinin TI, Lackman RD, Hornicek FJ, Ghandur-Mnaymneh femoral osteoarticular allografts after resection of bone tumors. Clin Orthop Relat Res 1994;303:103–15.
Abed YY, Beltrami G, Campanacci DA, Innocenti M, Scoccianti G, Capanna R. Biological reconstruction after resection of bone tumours around the knee: long-term follow-up. J Bone Joint Surg Br 2009;91:1366–72.
Peng RJ, Sun XF, Xiang XJ, Zhen ZJ, Ling JY, Tong GL, et al. Efficacy and survival of 92 cases of Ewing’s sarcoma family of tumor initially treated with multidisciplinary therapy. Ai Zheng 2009;28:1304–9.
Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010;116:1964–73.
Rodríguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 2008;19:814–20.
Toni A, Neff JR, Sudanese A, Ciaroni D, Bacci G, Picci P, et al. The role of surgical therapy in patients with nonmetastatic Ewing’s sarcoma of the limbs. Clin Orthop Relat Res 1993;286:225–40.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rastogi, S., Kumar, A., Gupta, H. et al. Short-term followup after surgical treatment of Ewing’s sarcoma. IJOO 44, 384–389 (2010). https://doi.org/10.4103/0019-5413.69308
Published:
Issue Date:
DOI: https://doi.org/10.4103/0019-5413.69308